SEMAGLUTIDE is a GLP-1 (glucagon-like peptide-1) analog that helps reduce appetite, slow stomach emptying, and improve blood sugar control, thus facilitating weight loss and diabetes management
The majority of evidence supporting the practice of microdosing GLP-1 medications, however, comes from anecdotal evidence and reported benefits from patients and clinicians
Absolute Contraindications Personal or family history of medullary thyroid cancer: GLP-1 class medications have caused thyroid tumors in rodent studies
If take-back programs are not available, the FDA recommends mixing the medication with an unpalatable substance such as coffee grounds or cat litter, sealing it in a container, and disposing of it in household trash after removing or obscuring personal information on the prescription label
Strenuous exercise provokes severe muscle damage characterized by ultrastructure changes, macrophages infiltration, inflammatory cytokines production and oxidative stress paralleled by GSH decrement and increased GSSG production [55,112]
